MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, APRE has $15,933,401 in assets. $14,599,347 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
562.92%
Quick Ratio
562.92%
Cash Ratio
528.13%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other noncurrent assets
    • Restricted cash
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accumulated other comprehensive ...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
14,599,347
Prepaid expenses and other current assets
961,899
Total current assets
15,561,246
Property and equipment, net
59,807
Restricted cash
41,186
Other noncurrent assets
271,162
Total assets
15,933,401
Accounts payable
713,668
Accrued expenses
2,050,690
Total current liabilities
2,764,358
Series a convertible preferred stock, 0.001 par value, 40,000,000 shares authorized 31,194 and 56,227 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively
727,361
Common stock, 0.001 par value, 400,000,000 shares authorized, 8,192,538 and 5,481,055 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively
8,192
Additional paid-in capital
356,709,645
Accumulated other comprehensive loss
-10,634,714
Accumulated deficit
-333,641,441
Total stockholders' equity
12,441,682
Total liabilities and stockholders' equity
15,933,401
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$14,599,347 Prepaid expenses andother current assets$961,899 Total current assets$15,561,246 Other noncurrentassets$271,162 Property and equipment,net$59,807 Restricted cash$41,186 Total assets$15,933,401 Total liabilities andstockholders' equity$15,933,401 Total stockholders'equity$12,441,682 Total currentliabilities$2,764,358 Series a convertiblepreferred stock, 0.001 par...$727,361 Accumulated deficit-$333,641,441 Accumulated othercomprehensive loss-$10,634,714 Additional paid-in capital$356,709,645 Accrued expenses$2,050,690 Accounts payable$713,668 Common stock, 0.001 parvalue, 400,000,000...$8,192

Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics, Inc. (APRE)